Iowa Sleep Blog

New medication

Friday, May 24, 2013

Federal advisory panel on Wednesday endorsed  Suvorexant (Merck product). FDA may approve by this fall.  

Suvorexant

belongs to a new class to insomnia agents which block orexin. Orexin is a excitatory neurotransmitter.    This would be the first in a new class and it works in a different manner than currently available drugs for insomnia.  

Before this we had agents that: 1)  increased GABA effect (benzos and nonbenzos),2)  agents that blocked the histamine (Silenor), and 3)  agents that worked on the SCN nucleus (Ramelteon).
-Dr Zorn

Thank you Dr Zorn/dkm

 

 

Comments
Post has no comments.
Post a Comment




Captcha Image

Trackback Link
http://www.iowasleep.com/BlogRetrieve.aspx?BlogID=16817&PostID=1018855&A=Trackback
Trackbacks
Post has no trackbacks.